FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutics and diagnostics. The invention represents a solid composition for oral administration in the form of a tablet applicable for the endoscopic diagnostic evaluation of intestine, containing at least one dye combined with at least one physiologically acceptable excipient.
EFFECT: invention provides the controlled intestinal release solid composition for oral administration.
17 cl, 12 tbl, 6 dwg, 12 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SOLID ORAL COMPOSITION CONTAINING COLORS FOR APPLICATION IN ENDOSCOPIC DIAGNOSTICS | 2013 |
|
RU2649783C2 |
| MESALAZINE TABLET WITH IMPROVED SOLUBILITY | 2011 |
|
RU2610435C2 |
| METHOD FOR TREATING INTESTINAL DISEASES PRESENTING AT LEAST ONE INFLAMMATORY COMPONENT | 2013 |
|
RU2649807C2 |
| PHARMACEUTICAL AND/OR FOOD COMPOSITIONS OF SHORT-CHAIN FATTY ACIDS | 2010 |
|
RU2528106C2 |
| COMPOSITION FOR USE IN TREATMENT OF INTESTINAL DAMAGE | 2017 |
|
RU2772870C2 |
| GASTRORESISTANT PHARMACEUTICAL COMPOSITIONS CONTAINING RIFAXIMIN | 2006 |
|
RU2403015C2 |
| LACTOFERRIN FOR TREATING IBD CAUSED BY BACTERIAL INVASION | 2014 |
|
RU2689987C2 |
| SOLID COMPOSITION FOR DELIVERY | 2018 |
|
RU2812928C2 |
| NIMESULIDE-CONTAINING SUSTAINED-RELEASE COMPOSITIONS | 2000 |
|
RU2238087C2 |
| SOLID PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION | 1992 |
|
RU2120798C1 |
